A carregar...
Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)
PURPOSE: Examine the use of systemic phosphodiesterase inhibition (sildenafil) to clear central serous chorioretinopathy (CSCR). OBSERVATIONS: In a long-standing CSCR patient, sildenafil produced a rapid resolution. When discontinued (dechallenge) the CSCR returned. When rechallenged, the CSCR again...
Na minha lista:
| Publicado no: | Am J Ophthalmol Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7750488/ https://ncbi.nlm.nih.gov/pubmed/33364520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2020.100998 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|